Arno Therapeutics, Inc.
ARNI
$0.0001
$0.000.00%
OTC PK
| 09/30/2016 | 06/30/2016 | 03/31/2016 | 12/31/2015 | 09/30/2015 | |
|---|---|---|---|---|---|
| Net Income | -79.65% | 42.23% | 7.16% | -488.11% | 80.28% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -100.00% | 320.83% | -- | -- |
| Total Other Non-Cash Items | 2,999.90% | -105.80% | -3.96% | 248.70% | -406.84% |
| Change in Net Operating Assets | -158.19% | 174.02% | -2,222.49% | 89.10% | -164.84% |
| Cash from Operations | 32.13% | 36.72% | -23.89% | 4.51% | 12.54% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 300.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -11.11% | 0.00% | 0.00% | -12.50% | 0.00% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 65.96% | -2,532.00% | 80.00% | -- | -- |
| Cash from Financing | 3,588.61% | -101.27% | 152.65% | 260,925.00% | 0.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 167.94% | -166.74% | 4,748.31% | 97.49% | 12.53% |